Antibody-mediated Rejection Market Size, Trends, and Growth Outlook 2026-2033 The Antibody-mediated Rejection (AMR) market is witnessing transformative growth, driven by advancements in transplant immunology and targeted therapies. Market dynamics are heavily influenced by the rising incidence of organ transplants and evolving treatment protocols, creating significant business growth opportunities worldwide. Market Size and Overview The antibody-mediated rejection market is estimated to be valued at USD 142.7 Mn in 2025 and is expected to reach USD 331.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 12.8% from 2025 to 2032. https://www.coherentmi.com/industry-reports/antibody-mediated-rejection-market